Research programme: topical therapeutics for pain and nasal congestion - China Pharmaceutical University/ Johnson and Johnson InnovationAlternative Names: Nasal decongestants - China Pharmaceutical University, Johnson & Johnson Innovation; Pain therapeutics - China Pharmaceutical University, Johnson & Johnson Innovation
Latest Information Update: 04 Nov 2014
At a glance
- Originator China Pharmaceutical University; Johnson & Johnson Innovation
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Nasal congestion; Pain
Most Recent Events
- 29 Oct 2014 Early research in Nasal congestion and Pain in China (Topical)